Cargando…
P1472: INTERIM RESULTS OF SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS FROM AN ONGOING OPEN-LABEL STUDY INVESTIGATING FTX-6058 IN ADULTS LIVING WITH SICKLE CELL DISEASE
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429145/ http://dx.doi.org/10.1097/01.HS9.0000848744.04551.56 |
_version_ | 1784779344839704576 |
---|---|
author | Bruno, P. Kanter, J. Ziegler, J. Stuart, B. Ahn, J. Dunn, J. Allen, G. Morabito, C. |
author_facet | Bruno, P. Kanter, J. Ziegler, J. Stuart, B. Ahn, J. Dunn, J. Allen, G. Morabito, C. |
author_sort | Bruno, P. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9429145 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94291452022-08-31 P1472: INTERIM RESULTS OF SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS FROM AN ONGOING OPEN-LABEL STUDY INVESTIGATING FTX-6058 IN ADULTS LIVING WITH SICKLE CELL DISEASE Bruno, P. Kanter, J. Ziegler, J. Stuart, B. Ahn, J. Dunn, J. Allen, G. Morabito, C. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429145/ http://dx.doi.org/10.1097/01.HS9.0000848744.04551.56 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Bruno, P. Kanter, J. Ziegler, J. Stuart, B. Ahn, J. Dunn, J. Allen, G. Morabito, C. P1472: INTERIM RESULTS OF SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS FROM AN ONGOING OPEN-LABEL STUDY INVESTIGATING FTX-6058 IN ADULTS LIVING WITH SICKLE CELL DISEASE |
title | P1472: INTERIM RESULTS OF SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS FROM AN ONGOING OPEN-LABEL STUDY INVESTIGATING FTX-6058 IN ADULTS LIVING WITH SICKLE CELL DISEASE |
title_full | P1472: INTERIM RESULTS OF SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS FROM AN ONGOING OPEN-LABEL STUDY INVESTIGATING FTX-6058 IN ADULTS LIVING WITH SICKLE CELL DISEASE |
title_fullStr | P1472: INTERIM RESULTS OF SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS FROM AN ONGOING OPEN-LABEL STUDY INVESTIGATING FTX-6058 IN ADULTS LIVING WITH SICKLE CELL DISEASE |
title_full_unstemmed | P1472: INTERIM RESULTS OF SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS FROM AN ONGOING OPEN-LABEL STUDY INVESTIGATING FTX-6058 IN ADULTS LIVING WITH SICKLE CELL DISEASE |
title_short | P1472: INTERIM RESULTS OF SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS FROM AN ONGOING OPEN-LABEL STUDY INVESTIGATING FTX-6058 IN ADULTS LIVING WITH SICKLE CELL DISEASE |
title_sort | p1472: interim results of safety, tolerability, pharmacokinetics, and pharmacodynamics from an ongoing open-label study investigating ftx-6058 in adults living with sickle cell disease |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429145/ http://dx.doi.org/10.1097/01.HS9.0000848744.04551.56 |
work_keys_str_mv | AT brunop p1472interimresultsofsafetytolerabilitypharmacokineticsandpharmacodynamicsfromanongoingopenlabelstudyinvestigatingftx6058inadultslivingwithsicklecelldisease AT kanterj p1472interimresultsofsafetytolerabilitypharmacokineticsandpharmacodynamicsfromanongoingopenlabelstudyinvestigatingftx6058inadultslivingwithsicklecelldisease AT zieglerj p1472interimresultsofsafetytolerabilitypharmacokineticsandpharmacodynamicsfromanongoingopenlabelstudyinvestigatingftx6058inadultslivingwithsicklecelldisease AT stuartb p1472interimresultsofsafetytolerabilitypharmacokineticsandpharmacodynamicsfromanongoingopenlabelstudyinvestigatingftx6058inadultslivingwithsicklecelldisease AT ahnj p1472interimresultsofsafetytolerabilitypharmacokineticsandpharmacodynamicsfromanongoingopenlabelstudyinvestigatingftx6058inadultslivingwithsicklecelldisease AT dunnj p1472interimresultsofsafetytolerabilitypharmacokineticsandpharmacodynamicsfromanongoingopenlabelstudyinvestigatingftx6058inadultslivingwithsicklecelldisease AT alleng p1472interimresultsofsafetytolerabilitypharmacokineticsandpharmacodynamicsfromanongoingopenlabelstudyinvestigatingftx6058inadultslivingwithsicklecelldisease AT morabitoc p1472interimresultsofsafetytolerabilitypharmacokineticsandpharmacodynamicsfromanongoingopenlabelstudyinvestigatingftx6058inadultslivingwithsicklecelldisease |